Skip to main content
Top
Published in: Metabolic Brain Disease 3/2018

01-06-2018 | Original Article

Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice

Authors: Amrita A. Chowdhury, Nitin B. Gawali, Renuka Munshi, Archana R. Juvekar

Published in: Metabolic Brain Disease | Issue 3/2018

Login to get access

Abstract

Neuroinflammation is said to play a pivotal role in the pathogenesis of neurodegenerative disorders such as Alzheimer’s disease (AD). Trigonelline (TRG) is a naturally occurring alkaloid, commonly isolated from fenugreek and coffee beans. In the present study, we investigated whether TRG exerts neuroprotective action against LPS mediated cognitive impairment. Mice pretreated with TRG (50 and 100 mg/kg po) were administered with LPS (250 μg/kg ip) for 7 days. Memory was assessed in the Morris water maze (MWM) and Y maze. LPS administration caused poor memory retention in MWM and Y maze paradigms, and resulted in marked oxidative stress as evidenced by decrease in superoxide dismutase (SOD), reduced glutathione (GSH) levels and increased lipid peroxidation in the hippocampus and cortex. Cholinergic involvement during neuroinflammation was evaluated by measuring levels of acetylcholinesterase (AChE) enzyme. TRG treatment at both the doses reversed LPS induced behavioral and memory disturbances, significantly decreased the oxidative stress and AChE levels in both the hippocampus and cortex. LPS administration also elevated the tumour necrosis factor (TNF-α) and interleukin −6 (IL-6) levels, whereas brain derived neurotrophic factor (BDNF) levels were significantly depleted. TRG pretreatment led to decreased TNF-α and IL-6 levels and caused a significant upregulation of BDNF levels. In conclusion, present study highlights the promising neuroprotective role of TRG against LPS mediated cognitive impairment which could be attributed to reduced oxidative stress, inhibition of proinflammatory cytokines and restoration of BDNF levels.
Literature
go back to reference Arlt A, Sebens S, Krebs S, Geismann C, Grossmann M, Kruse M, Schreiber S, Schäfer H (2013) Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene 32(40):4825–4835. https://doi.org/10.1038/onc.2012.493 CrossRefPubMed Arlt A, Sebens S, Krebs S, Geismann C, Grossmann M, Kruse M, Schreiber S, Schäfer H (2013) Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene 32(40):4825–4835. https://​doi.​org/​10.​1038/​onc.​2012.​493 CrossRefPubMed
go back to reference Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177(2):751–766PubMed Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177(2):751–766PubMed
go back to reference Hou Y, Xie G, Miao F, Ding L, Mou Y, Wang L, Su G, Chen G, Yang J, Wu C (2014) Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibly via inhibiting microglia activation and protecting neuronal injury in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 54:92–102. https://doi.org/10.1016/j.pnpbp.2014.03.015 CrossRef Hou Y, Xie G, Miao F, Ding L, Mou Y, Wang L, Su G, Chen G, Yang J, Wu C (2014) Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibly via inhibiting microglia activation and protecting neuronal injury in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 54:92–102. https://​doi.​org/​10.​1016/​j.​pnpbp.​2014.​03.​015 CrossRef
go back to reference Ittner LM, Götz J (2011) Amyloid-β and tau—a toxic pas de deux in Alzheimer's disease. Nature. Rev Neurosci 12(2):67–72CrossRef Ittner LM, Götz J (2011) Amyloid-β and tau—a toxic pas de deux in Alzheimer's disease. Nature. Rev Neurosci 12(2):67–72CrossRef
go back to reference Ma L, Zhang H, Liu N, Wang PQ et al (2016) TSPO ligand PK11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic LPS administration. Brain Res. Bull 121:192–200CrossRefPubMed Ma L, Zhang H, Liu N, Wang PQ et al (2016) TSPO ligand PK11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic LPS administration. Brain Res. Bull 121:192–200CrossRefPubMed
go back to reference Mayakrishnan T, Nakkala JR, Jeepipalli SPK, Raja K, Chandra VK, Mohan VK, Sadras SR (2014) Fenugreek seed extract and its phytocompounds-trigonelline and diosgenin arbitrate their hepatoprotective effects through attenuation of endoplasmic reticulum stress and oxidative stress in type 2 diabetic rats. Eur Food Res Technol 240(1):223–232CrossRef Mayakrishnan T, Nakkala JR, Jeepipalli SPK, Raja K, Chandra VK, Mohan VK, Sadras SR (2014) Fenugreek seed extract and its phytocompounds-trigonelline and diosgenin arbitrate their hepatoprotective effects through attenuation of endoplasmic reticulum stress and oxidative stress in type 2 diabetic rats. Eur Food Res Technol 240(1):223–232CrossRef
go back to reference McCaulley ME, Grush KA (2015) Alzheimer’s disease: exploring the role of inflammation and implications for treatment. Int J Alzheimers dis. 2015. Article ID 515248 McCaulley ME, Grush KA (2015) Alzheimer’s disease: exploring the role of inflammation and implications for treatment. Int J Alzheimers dis. 2015. Article ID 515248
go back to reference Prince MJ (2015) World Alzheimer Report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International, London Prince MJ (2015) World Alzheimer Report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International, London
go back to reference Singh M, Kaur M, Kukreja H, Chugh R, Silakari O, Singh D (2013) Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection. Eur. J. Med Chem 70:165–188 Singh M, Kaur M, Kukreja H, Chugh R, Silakari O, Singh D (2013) Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection. Eur. J. Med Chem 70:165–188
go back to reference Xiao S, Wang T, Ma X, Qin Y, Li X, Zhao Z, Liu X, Wang X, Xie H, Jiang Q (2017) Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a phase II multicenter randomised controlled trial. Age Ageing:1–7 Xiao S, Wang T, Ma X, Qin Y, Li X, Zhao Z, Liu X, Wang X, Xie H, Jiang Q (2017) Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a phase II multicenter randomised controlled trial. Age Ageing:1–7
go back to reference Zhang D-F, Zhang F, Zhang J, Zhang R-M, Li R (2015) Protection effect of trigonelline on liver of rats with non-alcoholic fatty liver diseases. Asian Pac J. Trop Biomed 8(8):651–654 Zhang D-F, Zhang F, Zhang J, Zhang R-M, Li R (2015) Protection effect of trigonelline on liver of rats with non-alcoholic fatty liver diseases. Asian Pac J. Trop Biomed 8(8):651–654
Metadata
Title
Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice
Authors
Amrita A. Chowdhury
Nitin B. Gawali
Renuka Munshi
Archana R. Juvekar
Publication date
01-06-2018
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 3/2018
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-017-0147-5

Other articles of this Issue 3/2018

Metabolic Brain Disease 3/2018 Go to the issue